B+
Bull case
30%
Probability
Target price
$19.00
Analysis reference price unavailable
Analysis 2026-05-14 · RankAlpha Sentiment Codex
AUPH
AuriniaBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The post-earnings bull case is that Aurinia is still showing clean LUPKYNIS growth, strong profitability, positive operating cash flow, and enough balance-sheet capacity to pursue buybacks and pipeline expansion at the same time. The Kezar transaction also creates a second leg of optionality beyond the legacy single-product story.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +3.0.
What can break
2026 guidance was reiterated, not raised, which can disappoint after a strong run and makes the quarter look more like steady execution than acceleration.
Momentum
45
Value
69
Sentiment
66
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $17.00 · Bull $19.00 · Bear $13.00Analysis 2026-05-14; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-14 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $18.00
Why
Momentum45 · Δ7d -30.4
Value69 · Δ7d -0.0
Sentiment66 · Δ7d +3.0
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +3.0.
Contradictions & invalidation
- • 2026 guidance was reiterated, not raised, which can disappoint after a strong run and makes the quarter look more like steady execution than acceleration.
- • Cash and investments remain strong, but quarter-end balances declined versus year-end partly due to share repurchases and financing outflows.
- • The bear case is that Q1 was good but not obviously thesis-changing because 2026 guidance was reiterated rather than raised, revenue remains heavily concentrated in LUPKYNIS, and the Kezar deal adds execution and integration risk before it adds clear value.
Catalyst clock
2026-06-30
Q1 earnings beat with reiterated 2026 sales outlook
Lead driver: Sentiment · See AI snapshot
Momentum
45
9% active weight
Current posture
7d trendSoftening
Δ7d
-30.4
Δ21d
+16.2
Value
69
28% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+2.2
Sentiment
66
62% active weight
Current posture
7d trendImproving
Δ7d
+3.0
Δ21d
-1.7
Why this grade
Composite grade B. Momentum 45.2 / Value 68.6 / Sentiment 65.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-05-14. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$17.00
Analysis reference price unavailable
Analysis 2026-05-14 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$13.00
Analysis reference price unavailable
Analysis 2026-05-14 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$2.03B
Beta
1.52
Shares Out
133.05M
P/E (TTM)
27.3
P/S (TTM)
7.59
P/FCF (TTM)
16.83
Rev YoY
+18.9%
EPS YoY
+79.2%
Gross Margin
+90.4%
Op Margin
+45.2%
Net Debt
-$323.19M
Current Ratio
5.42
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data